MICHELE MURPHY: Open Payments
NPI 1821453044 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 44 payments from 16 companies in 2025. Trend: 2023 $664 · 2024 $598 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $148 |
| GlaxoSmithKline, LLC. | 6 | $100 |
| Novo Nordisk Inc | 5 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Eisai Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
Products named: TRELEGY ELLIPTA, Kerendia, ELIQUIS, Leqembi, REXULTI, PREVNAR 20, LEQVIO, Ozempic.
Industry payments across FL — which companies pay providers there.
